Kelly Lawrence W & Associates Inc Organon & Co. Transaction History

Kelly Lawrence W & Associates Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$23.31 - $28.61 $44,405 - $54,502	-1,905 Reduced 20.51%	7,383 $206,000
Q3 2022 Nov 15, 2022	SELL	$23.4 - $34.25 $2,854 - $4,178	-122 Reduced 1.3%	9,288 $218,000
Q1 2022 May 16, 2022	SELL	$30.45 - $39.36 $3,410 - $4,408	-112 Reduced 1.18%	9,410 $329,000
Q4 2021 Feb 11, 2022	SELL	$28.67 - $37.13 $12,987 - $16,819	-453 Reduced 4.54%	9,522 $290,000
Q3 2021 Nov 15, 2021	SELL	$28.63 - $35.64 $18,809 - $23,415	-657 Reduced 6.18%	9,975 $327,000
Q2 2021 Aug 16, 2021	BUY	$28.45 - $38.0 $302,480 - $404,016	10,632 New	10,632 $322,000

794

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.11B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Kelly Lawrence W & Associates Inc, based on Form 13F filings with the SEC.

Stay updated on Kelly Lawrence W & Associates Inc with notifications on news.